- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02776969
A Gene Hunting Study for Familial Papillary Thyroid Cancer
A Strategy to Search for Genes Predisposing to Papillary Carcinoma of the Thyroid When Mutated
Study Overview
Status
Conditions
Detailed Description
The aim of this project is to identify genetic risk factors associated with familial papillary thyroid carcinoma (PTC). This can be accomplished in several ways, including loss of heterozygosity studies as well as comparative gene expression analysis. When possible, linkage analysis on families with multiple individuals affected with PTC may also help identify the putative gene(s).
Study participants will be asked to:
- Complete family history and medical history questionnaires
- Sign a medical record release so that thyroid cancer pathology reports can be obtained
- Supply a blood or saliva sample for genetic studies
- Provide study related information to family members who are needed for family studies
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Ohio State University Comprehensive Cancer Center
- Phone Number: 614-293-5066
- Email: OSUCCCClinicaltrials@osumc.edu
Study Contact Backup
- Name: Pamela Brock, LGC
- Phone Number: 614-293-3147
- Email: Pamela.Brock@osumc.edu
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Recruiting
- Ohio State University Comprehensive Cancer Center
-
Contact:
- Pam Brock, LGC
- Phone Number: 614-293-3147
- Email: Pamela.Brock@osumc.edu
-
Principal Investigator:
- Matthew Ringel, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with a diagnosis of PTC and a family history of PTC in 3 or more living relatives
Affected and unaffected family members of the proband*
- For familial cases (families with 4 or more cases of PTC), participation will be offered to all living family members with PTC or benign thyroid disease as well as selected unaffected first and second degree relatives. Participation may also be offered to spouses when needed for analyzing parent/offspring samples.
Exclusion Criteria:
- Known germline predisposition (ex: pathogenic PTEN variant)
- Non-English speaking
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Genetic variants associated with familial papillary thyroid cancer as assessed by multiple genetic testing methodologies
Time Frame: Up to 5 years
|
Variants will be assessed for segregation within families, expression in the normal thyroid and/or thyroid cancer, and functional significance
|
Up to 5 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Matthew Ringel, MD, Ohio State University Comprehensive Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- OSU-9812
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid
-
Aarhus University HospitalOdense University Hospital; University of AarhusEnrolling by invitationThyroid Cancer | Thyroid Nodule (Diagnosis)Denmark
-
National Cancer Institute (NCI)TerminatedInsular Thyroid Cancer | Recurrent Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid Cancer | Anaplastic Thyroid Cancer | Stage III Follicular Thyroid Cancer | Stage III Papillary Thyroid CancerUnited States
-
Wuhan UniversityRecruitingThyroid Carcinoma | Thyroid Nodule (Benign) | Ablation; RetinaChina
-
AllerganCompletedHypothyroidism | Thyroid Disease | Euthyroid | Thyroid Gland | Thyroid HormonesUnited States
-
Rigen BiotechRenJi Hospital; Tianjin Medical University Cancer Institute and Hospital; Guangdong... and other collaboratorsRecruitingThyroid Cancer | Thyroid NoduleChina
-
University of FloridaNational Cancer Institute (NCI)RecruitingThyroid Cancer | Thyroid NodulesUnited States
-
Inha University HospitalRecruitingThyroid Cancer | Thyroid NoduleKorea, Republic of
-
Shanghai 10th People's HospitalUnknown
-
Boston Medical CenterCompletedThyroid Neoplasms | Thyroid Cancer | Thyroid NoduleUnited States
-
Assiut UniversityNot yet recruitingBenign Thyroid Nodule | Thyroid Lump | Thyroid Cyst